United States

Nektar Therapeutics is a biopharmaceutical company that develops medicines for unmet medical needs. Its products include Bempegaldesleukin, NKTR-358, NKTR-255, and NKTR-262, which are in various stages of clinical trials for the treatment of cancer, autoimmune diseases, and COVID-19. The company has collaboration agreements with several pharmaceutical companies. Nektar Therapeutics was founded in 1990 and is based in San Francisco, California.

Nektar Therapeutics

Biopharmaceutical company developing medicines.

Google

Menadžer proizvoda

Naučnik podataka

Nektar Therapeutics

Nektar Therapeutics Otvoreni poslovi

Da li ste spremni da unapredite svoju karijeru? Pogledajte ove otvorene pozicije u Nektar Therapeutics.